ripekg:author/RIPEAU5858064B63619835Hu Zhou |
rdf:type |
node1 |
ripekg:author/RIPEAU5858064B63619835Hu Zhou |
rdf:type |
rdfs:Resource |
ripekg:author/RIPEAU5858064B63619835Hu Zhou |
rdf:type |
owl:Thing |
ripekg:author/RIPEAU5858064B63619835Hu Zhou |
rdf:type |
prov:Person |
ripekg:author/RIPEAU5858064B63619835Hu Zhou |
rdf:type |
foaf:Person |
ripekg:author/RIPEAU5858064B63619835Hu Zhou |
rdf:type |
ripe:AuthorAuthor |
ripekg:author/RIPEAU5858064B63619835Hu Zhou |
owl:sameAs |
https://semopenalex.org/author/A5100927502 |
ripekg:author/RIPEAU5858064B63619835Hu Zhou |
foaf:familyName |
Zhou |
ripekg:author/RIPEAU5858064B63619835Hu Zhou |
foaf:givenName |
Hu |
ripekg:author/RIPEAU5858064B63619835Hu Zhou |
foaf:name |
Hu Zhou |
ripekg:retraction-notice/46572Potential Progression Mechanism and Key Genes in Early Stage of mTBI |
ripe:concerns |
ripekg:author/RIPEAU5858064B63619835Hu Zhou |
ripekg:work/10.1136%2Fbmj-2025-084314Anti-CD38 monoclonal antibody CM313 for primary immune thrombocytopenia: multicentre, randomised, placebo controlled, phase 2 trial |
dcterms:creator |
ripekg:author/RIPEAU5858064B63619835Hu Zhou |